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Objective. Most women with type I endometrial cancer (EC) are obese, increasing the risk of morbidity and mortality in this
population. The study objective was to evaluate the impact of obesity on quality of life (QOL) and general health status in EC
survivors with early-stage disease. Methods. A prospective ancillary analysis of stage I/II EC survivors. The association of BMI with
QOL questionnaire variables measured with the functional assessment of cancer therapy (subscales: physical (PWB), functional
(FWB), social, and emotional well-being) and the physical (PCS) and mental component summary subscales of the short-form
medical outcomes survey was determined. Results. 152 women completed both questionnaires; 81% were obese. After multiple
linear regression, BMI was inversely associated with PWB (P = .001), FWB (P = 0.048), and PCS (P = .001). Conclusions. Despite
the good prognosis associated with early-stage EC, QOL, and physical health are not optimized in obese survivors. This paper
highlights the importance of incorporating health-related QOL assessments and obesity interventions during the survivorship
period.
1.Introduction
Outcomes research in the last decade has evolved beyond
investigating conventional clinical endpoints to incorporat-
ing quality of life (QOL) endpoints, or direct assessments of
how patients feel [1]. To that end, both the NCI and FDA
havemandatedthatthegoalsofcancertherapiesshouldbeto
improve both survival and QOL [1, 2] .A sar e s u l to fe a r l i e r
detection and improvement in therapies, many women with
a cancer diagnosis are living longer, and therefore, there has
been considerable interest in studying health-related QOL
outcomes in cancer survivors after treatment.
Women with endometrial cancer comprise a large seg-
ment of female cancer survivors. Endometrial cancer, the
most common gynecologic malignancy in the USA, was di-
agnosed in over 42.000 women in 2010 [3]. One of the most
signiﬁcant risk factors for this cancer is obesity. Most women
with endometrial cancer are overweight or obese and possess
signiﬁcant obesity-driven comorbidities that threaten their
long-term health and QOL [4, 5]. It is well established that
obese women without cancer have poorer health outcomes
and QOL than their nonobese counterparts [6]. However,
little is known about the eﬀects of obesity on QOL and
physical health of endometrial cancer survivors beyond the
completion of therapy.
Several epidemiologic studies have linked obesity with
an increased rate of death from all causes, including cancer
[4, 7–12]. A recent prospective cohort study examining the
relationship of obesity to mortality in males and females
diagnosed with several diﬀerent cancers found that the
relative risk of cancer-related death in morbidly obese
women with endometrial cancer was 6.25—the highest rate2 Obstetrics and Gynecology International
of all deaths reported amongst the study subjects [11]. It
is evident from this and other reports that although most
endometrial cancer survivors have a good cancer prognosis
with the potential for long-term survival, their obesity puts
them at risk for morbidity and mortality. Despite this, most
obese endometrial cancer survivors do not adopt weight
loss or healthier lifestyle modiﬁcations after their cancer
diagnosis [12].
We hypothesized that increasing obesity would adversely
impact general health and QOL in this cancer patient cohort.
The aims of this study were to investigate the eﬀect of obesity
on general health status and QOL in women with early-stage
endometrial cancer.
2.MaterialsandMethods
2.1. Patients. After obtaining informed consent and insti-
tutional review board approval, prospective ancillary QOL
data were obtained from three previously published trials
on women with stage I-II endometrial cancer [5, 12, 13].
These trials were conducted at two participating gynecologic
oncology centers in Northeastern Ohio (University Hospitals
Case Medical Center, Cleveland, Ohio, and Akron General
MedicalCenter,Akron,Ohio).Ofnote,althoughtwoofthese
studies were interventional trials, all QOL assessments were
made prior to any interventions. Women who underwent a
primary surgical staging procedure with or without adjuvant
radiation therapy and were recurrence-free at the time of
their post-treatment interview were eligible. QOL ques-
tionnaires were completed a minimum of 6 months and a
maximum of 36 months after primary surgery/adjuvant
treatment.
Demographic data were collected by interview with a
research assistant and from medical record chart review.
Height and weight were obtained at the time of question-
naire completion by a nurse. Body mass index (BMI) was
calculated (weight (kg) divided by height (m2)) and catego-
rized as normal/overweight (18.5–29.9), obese (30–39.9), or
morbidly obese (≥40).
2.2. Instruments. General health status was measured with
the short-form medical outcomes survey (SF-36), a com-
prehensive survey designed to measure physical and mental
health.Scalesonthisquestionnaireincludethephysicalcom-
ponent summary (PCS) and mental component summary
(MCS) [14]. This 36-question scale assesses eight health
concepts: (1) limitations in physical activities because of
health problems; (2) limitations in social activities because
of physical or emotional problems; (3) limitations in usual
role activities because of physical health problems; (4) bodily
pain; (5) general mental health (psychological distress and
well-being); (6) limitations in usual role activities because
of emotional problems; (7) vitality (energy and fatigue);
(8) general health perceptions. Fatigue was also speciﬁcally
measured (as deﬁned by ≤46 on the SF-36 vitality subscale)
[15].
QOL was measured with the functional assessment of
cancer therapy (FACT-G), a 27-item core questionnaire
evaluating physical, functional, social, and emotional well-
being within the previous 7 days (PWB, FWB, SWB, and
EWB). The FACT-G is a reliable and validated instrument
for measuring QOL in cancer patients, including the elderly
[16, 17].
2.3. Statistical Analysis. One-way comparisons of variance
(ANOVA) with posthoc analysis was used to compare FACT-
G domains and SF-36 measures between categories of BMI
(normal/overweight (BMI ≤ 30), obese (BMI 30.0–39.9),
and morbidly obese (BMI ≥ 40). Items within each domain
are summed, with higher scores indicating higher QOL.
BMI was analyzed as a continuous variable, and Spearman
correlation coeﬃcients were calculated for BMI with SF-36
PCS, MCS, and FACT-G domains. In addition, Spearman
correlation coeﬃcients were calculated for individual line
items of the four FACT-G domains and for the eight SF-
36 subscales with BMI. Individual items within the FACT-G
were left as worded for the correlation analysis.
Multiple regression analysis was used to assess the eﬀect
ofBMIonFACT-GdomainandSF-36summaryscoreswhile
controlling for patient demographic, clinical, and treatment
(radiation therapy) variables. Variables included were age,
educational level, marital status, radiation treatment, time
since diagnosis, and smoking. Educational level was catego-
rizedas<16yearsversus ≥16years(collegedegreeorhigher),
and smoking was categorized according to <5.0 versus ≥5.0
pack years. Continuous variables in the model included age,
BMI, and time since diagnosis (months). Variables were
regressedonindividualFACT-Gdomains(PWB,FWB,SWB,
and EWB) and SF-36 summary measures (PCS, MCS) using
astepwiselinearregressionprocedure.Variableswereentered
in the regression models at a probability level of P<0.05
and were removed at a probability level >0.10. Collinearity
diagnostics (tolerance and variance inﬂation factor) were
examined to assess multicollinearity of variables included in
the ﬁnal model. Exploratory analysis using the SF-36 vitality
subscale was conducted to assess fatigue in this dataset.
Presence of fatigue was deﬁned as ≤46 on the vitality SF-36
subscale [18]. SPSS version 14.0 (Chicago, Ill) was used for
analysis.
3. Results
One hundred ﬁfty-two women completed questionnaires
within 6–36 months after treatment (median 14.6 months).
Demographic data is presented in Table 1.M e a ns u b j e c ta g e
was 57, and performance status was zero in 95%. Forty
two percent of subjects graduated from college, 61% were
married, 93% percent had stage I disease, and less than
half of the women received adjuvant radiation treatment.
Eighty-onepercentofthewomenwereobese(meanBMIwas
37.5kg/m2). Forty-ﬁve percent of participants completed
the questionnaire within 1 year of their cancer diagnosis,
20% within 2 years, and 35% at 2-3 years from diagnosis.
Notably, the timing of questionnaire administration was not
signiﬁcantly diﬀerent among the normal/overweight versusObstetrics and Gynecology International 3
Table 1: Patient demographics and clinical variables, n = 152.
Age, mean (SD), range 57.7 (11.0), range 32–87
Performance status
0 145 (95%)
17 ( 5 % )
Body mass index (kg/m2), mean
(SD), range 37.5 (8.7), range 22.5–64.7
<30 29 (19.1%)
30–39 69 (45.4%)
≥40 54 (35.5%)
Adjuvant radiation therapy 61 (40%)
Smoking
Never 111 (73.0%)
<5.0 pack years 5 (3.3%)
≥5.0 pack years 36 (23.7%)
Education
High school 45 (29.6%)
Some college 42 (27.6%)
College graduate or higher 65 (42.8%)
Stage of cancer
I 141 (92.8%)
II 11 (7.2%)
Married 93 (61.2%)
Selected comorbidities
Hypertension 70 (46.1%)
Diabetes mellitus 34 (22.4%)
Time since diagnosis (months),
median 14.6
Race
Caucasian 143 (94.1%)
African American 7 (4.6%)
Other 2 (1.3%)
n (%) presented unless otherwise noted.
obese and morbidly obese patients (P = .210), nor did QOL
scores signiﬁcantly diﬀer based on questionnaire timing.
One-way ANOVA revealed a signiﬁcant diﬀerence overall
among BMI groups for the SF-36 PCS score and the PWB
domain FACT-G (Table 2). On post hoc analysis, morbidly
obese endometrial cancer patients had a signiﬁcantly lower
SF-36 PCS score than their normal/overweight (P = 0.002)
and obese counterparts (P = .05). For FACT-G PWB, obese
and morbidly obese patients had a signiﬁcantly lower score
as compared to normal/overweight patients (P = .004 and
P = .001, resp.). Scores did not diﬀer between obese and
morbidly obese patients (P = .800) for the PWB domain.
To further assess the impact of increasing BMI on QOL
measures and general health, correlations were performed
with FACT-G domains and SF-36 summary measures
(Table 3). BMI was inversely correlated with PWB and
FWB domain scores. Within the PWB domain, BMI was
correlated with several line items, including “lack of energy”
and “meeting needs of family.” Within the FWB domain,
Table 2: FACT-G and SF-36 means overall and by body mass index.
Normal/overweight
(n = 29)
Obese
(n = 69)
Morbidly
obese
(n = 54)
P value∗
SF-36
PCS 49.7 (9.7) 45.7 (9.2) 41.4 (10.9) .001
MCS 54.8 (9.0) 50.7 (10.2) 50.8 (12.1) .217
FACT-G
PWB 26.5 (1.4) 23.9 (4.0) 23.5 (3.4) .001
SWB 19.2 (4.6) 18.1 (4.5) 17.5 (4.1) .293
EWB 20.0 (3.6) 19.8 (4.0) 19.1 (4.8) .632
FWB 22.5 (6.3) 21.8 (5.4) 21.0 (5.2) .492
Total 88.1 (11.5) 83.6 (13.5) 81.2 (14.1) .098
Mean (SD) values presented.
∗one-way ANOVA for comparison of normal/overweight, obese, and
morbidly obese groups.
“ability and fulﬁllment of work,” “enjoyment of life,” “things
I usually do for fun,” and “content with QOL right now”
were all inversely correlated with BMI. On SF-36, BMI was
inversely correlated with PCS total score and all subscales
except for mental health.
Multiple regression analyses were conducted to examine
the impact of BMI on FACT-G and SF-36 scores while con-
trolling for patient demographic and clinical variables
(Table 4). BMI remained a signiﬁcant factor aﬀecting PWB
and FWB domains of the FACT-G (P = .001, P = 0.048) and
SF-36 PCS (P<. 001). Of note, age was a signiﬁcant factor
aﬀecting SF-36 PCS and MCS scores, and the FACT-G EWB
score and marital status also signiﬁcantly impacted FACT-
G PCS, with unmarried women having signiﬁcantly poorer
scores. The combination of increasing age and BMI further
decreased QOL scores. (standardized beta for BMI = −.420,
age = −.367). Smoking was also a signiﬁcant factor aﬀecting
FACT-G PWB and EWB.
Fatigue was present in 43 (28.3%) of women. Mean (SD)
BMI of those having fatigue was 41.0 (8.7) as compared to
36.5 (8.6) without fatigue (P = .006). Finally, 61 patients
(40%) received adjuvant radiation therapy; treatment did
n o ti m p a c tF A C T - Go rS F - 3 6s c o r e so rp r e s e n c eo ff a t i g u e .
4. Discussion
Previous research has demonstrated that obesity in women
without cancer is associated with poorer health-related
quality of life [18, 19]. A recent study of 9094 female and
male participants in the Canadian Multicentre Osteoporosis
Study demonstrated that increasing BMI, particularly in
women, had a signiﬁcant negative impact on health and
QOL [7]. Similarly, our study demonstrates that increasing
obesity is associated with lower health-related QOL in
endometrial cancer survivors, as demonstrated in analysis
of several domains of the FACT-G and SF-36 scales. On
domain line-item analysis, BMI was not only signiﬁcantly
correlated with poor physical health scores and lack of
energy but also inversely correlated with several functional4 Obstetrics and Gynecology International
Table 3: Correlations between FACT domains, SF36 (PCS, MCS),
and BMI.
FACT Domain Body mass index
Physical −.320∗∗
Lack of energy .363∗∗
Nausea .114
Meeting needs of family .264∗∗
Pain .125
Side eﬀects of treatment .001
Feel ill .115
Forced to spend time in bed .108
Functional −.175∗
Ability to work −.187∗
Fulﬁllment of work −.201∗
Able to enjoy life −.208∗
Accepted my illness −.132
Sleeping well .073
Enjoy things I usually do for fun −.228∗∗
Content with QOL right now −.216∗∗
Social −.142
Closeness to friends .170∗
Emotional support from family .011
Support from friends −.013
Family acceptance of illness −.024
Satisﬁed with family communication .144
Close to partner −.015
Satisﬁed with sex life −.095
Emotional −.081
Sadness .116
Satisﬁed with coping with illness −.016
Losing hope .137
Nervous .037
Worry about dying .065
Worry condition will get worse .041
PCS −.326∗∗
Physical functioning −.389∗∗
Role physical −.220∗∗
Bodily pain −.189∗
General health −.325∗∗
MCS −.090
Vitality −.256∗∗
Social functioning −.231∗∗
Role emotional −.213∗∗
Mental health −.094
∗P< . 05.
∗∗P<. 01.
domain scores including lack of fulﬁllment of work and
enjoyment of life. Because endometrial cancer is often
diagnosed at an early stage, and therefore, may be curable,
enhancing the quality of life of survivors is a high priority.
Yet QOL gains are elusive in this population as there is a
high prevalence of obesity among survivors, and therefore, a
signiﬁcant proportion of survivors with associated sedentary
lifestyles and possession of obesity-driven comorbidities.
Physicalinactivityandobesityaﬀectsurvivors’health-related
QOL, either independently or through their association with
chronic diseases. These and other obesity-driven factors put
endometrial cancer survivors at increased risk for major
public health problems such as heart disease, diabetes, oste-
oarthritis, and stroke. Furthermore, according to a prospec-
tiveobservationalcohortstudybyCalleetal.,obesesurvivors
are also at risk of recurrent endometrial cancer and other
malignancies as well when compared to their thinner coun-
terparts [11].
However, few studies have addressed the impact of obe-
sity and its associated comorbidities on QOL in this cancer
cohort. Limitations of prior research have included het-
erogeneous gynecologic populations and diﬀerent adjuvant
therapies [20–22]. Klee and Machin assessed 49 women with
endometrial cancer who received adjuvant radiation therapy
and concluded that most patients experience physical side
eﬀects and have overall lower QOL compared to a matched
population of healthy women [20]. van de Poll-Franse noted
good overall QOL in endometrial cancer survivors although
QOL scores were lower in those who had received adjuvant
therapy [22]. By contrast, in our study, poor overall physical
domain and health-related QOL scores were observed. This
may be due to the more obese population represented in our
analysis when compared to the European studies referenced
above. Furthermore, our study did not note any diﬀerence in
scores between women who had received adjuvant radiation
versus those who did not. This may be because subjects were
surveyed several months after the completion of therapy,
and therefore, QOL diﬀerences based on adjuvant treatment
status may have not been apparent.
It is understood that increasing BMI and a sedentary
lifestyle has an adverse eﬀect on health and QOL on can-
cer survivors. In a study of 386 endometrial cancer survivors
who were surveyed about exercise and BMI, investigators
showed that lack of exercise and excess body weight exac-
erbated treatment-related declines in QOL [6]. Multivari-
ate analyses showed that healthy, ﬁt endometrial cancer
survivors reported signiﬁcantly better QOL than did unﬁt,
o b e s es u r v i v o r sa n dt h a tb o t he x e r c i s e( P<0.001) and
BMI (P<0.001) were independently associated with
QOL. While obesity is a leading risk factor for endometrial
cancer and also increases the risk of cancer-related and all-
cause mortality in survivors, previous work from our group
demonstrates that the majority of survivors are not making
lifestyle modiﬁcations that positively impact upon their
obesity or associated comorbidities after cancer treatment
[5, 12]. When surveyed, most female cancer survivors want
to make positive lifestyle modiﬁcations, with the most
commongoalsbeingimprovingphysicalactivity,performing
meaningful activities, losing weight, and eating a better diet
[23]. von Gruenigen et al. demonstrated that only 12% of
endometrial cancer survivors exhibited lifestyle behaviors
recommended by the American Cancer Society for cancer
survivors, including adequate physical activity, ﬁve servings
of fruit and vegetables per day, and no smoking [12]. Basen-
Engquist et al. also reported in a separate QOL survey
study of 121 endometrial cancer survivors that most womenObstetrics and Gynecology International 5
Table 4: Multiple linear regression analysis for each FACT-G domain and SF-36 PCS and MCS scores.
Variables Standardized Beta coeﬃcient t value R, adjusted R2 F value, P value
FACT-G
PWB
BMI −.218 −2.72
.329, .089 5.69, P = .001 married −.206 −2.56
smoking −.168 −2.11
SWB time since diagnosis −.296 −3.71 .296,.081 13.73, P<. 001
EWB smoking −.218 −2.70 .273,.061 5.71, P = .004
age .169 2.10
FWB BMI −.165 −2.00 .165, .020 3.99, P = .048
SF-36
PCS BMI −.420 −5.44 .468 20.24, P<. 001
age −.367 −4.76 .209
MCS age .207 2.55 .207, .036 6.51, P = .012
exhibited a sedentary lifestyle which signiﬁcantly impacted
their health-related QOL and, as a general matter, were not
making positive lifestyle modiﬁcations after a diagnosis of
cancer [24].
Apart from the impact BMI had on perceived physi-
cal health and functioning in the current study, we also
demonstrated that morbid obesity in cancer survivors was
signiﬁcantly associated with fatigue. Although we did not
employ a speciﬁc fatigue instrument to study this variable,
previous studies have demonstrated that the use of the SF-36
vitality subscale is a reasonable surrogate tool for measuring
fatigue [18, 25, 26]. Fatigue is a common side eﬀect of
canceranditstreatment,anditfrequentlygoesunrecognized
and untreated [26]. While the etiology of fatigue is unclear,
numerous clinical factors, such as obesity, are likely contrib-
utors. It is also quite possible that fatigue may prevent these
cancer survivors from achieving healthier lifestyles through
dietary modiﬁcation and exercise. Therefore, these issues
should be addressed with all endometrial cancer patients in
the immediate posttreatment period when patients are most
likely to be motivated to modify their lifestyles.
Multiple linear regression analyses conﬁrmed the adverse
inﬂuence of higher BMI as well as increased age and smoking
on health-related QOL. Groessl et al. demonstrated in 1326
elderly adults (mean age 72) from the Rancho Bernardo
longitudinal cohort study that obese older adults had lower
QOL than those who are overweight or of normal weight
[19]. This supports the ﬁndings in our study that BMI has a
signiﬁcant impact on physical health and QOL independent
of age. Our study demonstrated that the additive eﬀects
of obesity and age in elderly endometrial cancer survivors
furtherdecreasedQOLscores.Physicianscaringforendome-
trial cancer survivors must, therefore, have an understanding
of the relationship between BMI, obesity-driven comor-
bidities, and post cancer-treatment symptom stress as well
as knowledge of patients’ functional/psychologic status and
potential age-related limitations that may impact on their
physical and mental health.
Study strengths include the prospective design and the
use of both general and speciﬁc validated QOL instruments.
This report is one of the most comprehensives examining
the impact of obesity on health-related QOL for endometrial
cancer survivors. Our study is limited by the post hoc
analysis, lack of racial diversity, possible selection bias, lack
of standardized data on physical activity, and by variations
in the timing of posttreatment interviews. However, 45%
of surveys were completed within the ﬁrst year after cancer
diagnosis, and timing of the surveys did not impact QOL
scores signiﬁcantly. In an eﬀort to address these limitations
and comprehensively address the question of obesity and
quality of life in endometrial cancer survivors, our research
group is actively conducting a prospective lifestyle interven-
tional trial.
5. Conclusions
Improving QOL should be a priority in the management
of cancer, especially for long-term survivors. Obesity poses
one of the greatest health threats to early-stage, endometrial
cancer patients after treatment and adversely impacts their
QOL. Morbidly obese endometrial cancer survivors have
an increased risk of low summary and line-item scores
for several health-related QOL domains, signifying the
importance of considering such factors in programs aimed
at obesity intervention for this population. These patients
require a comprehensive approach to medical care, and
interventional trials focused on weight reduction are needed
to assess the feasibility of improving speciﬁc QOL domains,
general health status, and long-term outcomes in this sur-
vivor population. Furthermore, trials of endometrial cancer
treatment should include a health-related QOL assessment
as this measure may lead to improvement of clinical care
by emphasizing the patients’ perspectives on the health and
QOL beneﬁts of cancer therapy.
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